Replies to post #85507 on Biotech Values

[dewophile]

idix

I can't recall who/when said it, but i'm pretty sure someone from management (i don't think it was JP), perhaps in response to a question alluding to the inform trials, said they feel a 3rd agent will be needed in the mix to move to all oral (which implies eliminating interferon, not ribavirin). i could have misheard - for sure my memory is not what it used to be, but it kind of stuck in my mind simply because of the obvious bias toward their business model